Clinical characteristics of patients with DLBCL
| . | Patients with HGAL 0.73 or higher . | Patients with HGAL lower than 0.73 . | All patients . | P . |
|---|---|---|---|---|
| No. patients | 24 | 30 | 54 | |
| Age, y | NS | |||
| Median (range) | 42 (21-65) | 55 (18-73) | 50 (18-73) | |
| Clinical stage* | NS | |||
| 1 | 1 | 6 | 7 | |
| 2 | 10 | 10 | 20 | |
| 3 | 3 | 2 | 5 | |
| 4 | 10 | 10 | 20 | |
| Performance status* | NS | |||
| 0-1 | 20 | 24 | 44 | |
| 2 or more | 3 | 3 | 6 | |
| B symptoms* | NS | |||
| Yes | 5 | 6 | 11 | |
| No | 19 | 21 | 40 | |
| LDH* | .04 | |||
| High | 7 | 17 | 24 | |
| Low | 15 | 9 | 24 | |
| Extranodal involvement | NS | |||
| Less than or equal to 1 | 19 | 16 | 35 | |
| Greater than 1 | 4 | 12 | 16 | |
| IPI* | NS | |||
| 0-2 | 19 | 17 | 36 | |
| 3-5 | 3 | 9 | 12 |
| . | Patients with HGAL 0.73 or higher . | Patients with HGAL lower than 0.73 . | All patients . | P . |
|---|---|---|---|---|
| No. patients | 24 | 30 | 54 | |
| Age, y | NS | |||
| Median (range) | 42 (21-65) | 55 (18-73) | 50 (18-73) | |
| Clinical stage* | NS | |||
| 1 | 1 | 6 | 7 | |
| 2 | 10 | 10 | 20 | |
| 3 | 3 | 2 | 5 | |
| 4 | 10 | 10 | 20 | |
| Performance status* | NS | |||
| 0-1 | 20 | 24 | 44 | |
| 2 or more | 3 | 3 | 6 | |
| B symptoms* | NS | |||
| Yes | 5 | 6 | 11 | |
| No | 19 | 21 | 40 | |
| LDH* | .04 | |||
| High | 7 | 17 | 24 | |
| Low | 15 | 9 | 24 | |
| Extranodal involvement | NS | |||
| Less than or equal to 1 | 19 | 16 | 35 | |
| Greater than 1 | 4 | 12 | 16 | |
| IPI* | NS | |||
| 0-2 | 19 | 17 | 36 | |
| 3-5 | 3 | 9 | 12 |
NS indicates no statistical difference.
Data were missing for some of the studied DLBCL patients in these categories.